These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1047 related items for PubMed ID: 17063089

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A case of congenital supratentorial tumor: atypical teratoid/rhabdoid tumor or primitive neuroectodermal tumor?
    Nishihira Y, Tan CF, Hirato J, Yoshimura J, Nishiyama K, Takahashi H, Fujii Y, Takahashi H.
    Neuropathology; 2007 Dec; 27(6):551-5. PubMed ID: 18021375
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Loss of INI1 protein expression defines a subgroup of aggressive central nervous system primitive neuroectodermal tumors.
    Miller S, Ward JH, Rogers HA, Lowe J, Grundy RG.
    Brain Pathol; 2013 Jan; 23(1):19-27. PubMed ID: 22672440
    [Abstract] [Full Text] [Related]

  • 7. Atypical teratoid/rhabdoid tumor with ganglioglioma-like differentiation: case report and review of the literature.
    Krishnan C, Vogel H, Perry A.
    Hum Pathol; 2014 Jan; 45(1):185-8. PubMed ID: 24034858
    [Abstract] [Full Text] [Related]

  • 8. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
    Fujisawa H, Misaki K, Takabatake Y, Hasegawa M, Yamashita J.
    J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
    [Abstract] [Full Text] [Related]

  • 9. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis.
    Sigauke E, Rakheja D, Maddox DL, Hladik CL, White CL, Timmons CF, Raisanen J.
    Mod Pathol; 2006 May; 19(5):717-25. PubMed ID: 16528370
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB.
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K, Yamada Y, Hotokebuchi Y, Yamamoto H, Taguchi T, Iwamoto Y, Oda Y.
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre.
    Rekhi B, Jambhekar NA.
    Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.